Observations and Commentary on Medicine and Current Events
Dr. Clifford Hudis, the ASCO CEO, shares ASCO’s approach to the continued ABIM-MOC saga. With many oncologists expressing their angst about the MOC process, ASCO, under his leadership, approached the situation methodically, sending a survey to its members to quantify the problem and explore next steps.
Join Chadi as he engages with Petros Grivas, MD, PhD, Professor in the Clinical Research division of Fred Hutchinson Cancer Center, to unravel the groundbreaking updates in bladder cancer revealed at the ESMO Congress.
Chadi is joined by two distinguished experts in the field of oncology and dermatology, Dr. Soo Park and Dr. Farah Abdulla. Together, they unravel the complexities of melanoma, non-melanoma, and non-cancerous dermatological diseases, shedding light on sun-related vs. non-sun related melanoma, race-related disparities in dermatologic malignancies, and the intricate choices between surgery and therapy options, including the sequencing of treatments.
Chadi sits down with Jennifer Mack, MD, MPH, pediatric oncologist at Dana-Farber Cancer Institute and Boston, to delve into the delicate art of communicating difficult news to cancer patients.
With Moshe Chasky and Lor Terzian of Alliance Cancer Specialists, Chadi explores the high-stakes lawsuit filed by Alliance against Jefferson Health and Thomas Jefferson University Hospitals, alleging anti-competitive practices that have reverberated throughout the healthcare industry.
Chadi is joined by Dr. Robert Brodsky, President of ASH, and Dr. Mikkael Sekeres, Chair of Communications at ASH, to discuss what led to the recent ASH statement on the ABIM MOC and to gather their reactions to the ABIM response and to what next steps might look like.
Shelly Rosenfeld, Director of the Disability Rights Legal Center, Cancer Legal Resource Center, joins the show to share some pearls of wisdom regarding the intersection between medical and legal concerns in cancer care.
Chadi sits down with three experts from the Cancer and Aging Research Group and contributors to the ASCO guideline on geriatric oncology: William Dale, MD, PhD, FASCO, City of Hope Comprehensive Cancer Center; Supriya Mohile, MD, MS, University of Rochester; and Heidi Klepin, MD, MS, Wake Forest University.